The dual role of NFATc1 as a repressor and activator of MARCH8 in pancreatic cancer cells depending on the cell type points out that there could be epigenetic differences in the MARCH8 promoter region. This evidence concerns the gene NFATC1 and familial pancreatic carcinoma.